Literature DB >> 11104387

On testing for drug/chemical interactions: definitions and inference.

C Gennings1.   

Abstract

The notion of zero interaction in the statistical literature is not always equivalent to what is found in the toxicology literature. A discussion about when they are the same is provided here. Design issues are of paramount importance in the analysis of drug combinations (mixtures of chemicals) when the number of constituents in the combination is larger than, say, three as the usual factorial designs are not feasible. An economical design necessary and sufficient to support the estimation of an additivity model is single drug (chemical) dose-response data. Once estimated, the additivity surface can be used to make comparisons to the observed data at combination points of interest. Examples are provided to demonstrate the methods.

Mesh:

Substances:

Year:  2000        PMID: 11104387     DOI: 10.1081/BIP-100101978

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  4 in total

1.  Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer.

Authors:  Leo Christopher DeRosier; Donald J Buchsbaum; Patsy G Oliver; Zhi-Qiang Huang; Jeffrey C Sellers; William E Grizzle; Wenquan Wang; Tong Zhou; Kurt R Zinn; Joshua W Long; Selwyn M Vickers
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

2.  Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.

Authors:  Patsy G Oliver; Albert F LoBuglio; Kurt R Zinn; Hyunki Kim; Li Nan; Tong Zhou; Wenquan Wang; Donald J Buchsbaum
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

3.  Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.

Authors:  Saber Dini; Sophie Zaloumis; Pengxing Cao; Ric N Price; Freya J I Fowkes; Rob W van der Pluijm; James M McCaw; Julie A Simpson
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

4.  Emax model and interaction index for assessing drug interaction in combination studies.

Authors:  J Jack Lee; Heather Y Lin; Diane D Liu; Maiying Kong
Journal:  Front Biosci (Elite Ed)       Date:  2010-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.